Anti-inflammatory effects of LASSBio-998, a new drug candidate designed to be a p38 MAPK inhibitor, in an experimental model of acute lung inflammation. Journal title: Pharmacological Reports Authors: Aline Brando Lima, Alexandre Machado, Patrícia Simon, Moisés Cavalcante, Daniele Rezende, Gilberto S... Subject(s):
Molecular Biology of Chronic Obstructive Pulmonary Disease from the Bases to the Therapeutic Decision: A Review Journal title: Journal of Advances in Medicine and Medical Research Authors: Alcibey Alvarado-González, Isabel Arce-Jiménez Subject(s):
Novel Simvastatin Inhalation Formulation and Characterisation Journal title: AAPS PharmSciTech Authors: Alaa S. Tulbah, Hui Xin Ong, Paolo Colombo, Paul M. Young, Daniela Traini Subject(s): Medicine
